Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Stock-based Compensation and Other Benefit Plans (Tables)

v3.22.2
Note 15 - Stock-based Compensation and Other Benefit Plans (Tables)
6 Months Ended
Jun. 30, 2022
Notes Tables  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2022

   

2021

   

2022

   

2021

 
   

(in thousands)

 

Stock-based compensation - equity awards

  $ 615     $ 117     $ 1,019     $ 440  

Stock-based compensation - liability awards

    227       397       1,245       1,633  

Total stock-based compensation

  $ 842     $ 514     $ 2,264     $ 2,073  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

Six Months Ended June 30,

 
   

2022

   

2021

 

Weighted average exercise price - ($/share)

  $ 6.41     $ 3.14  

Expected life in years

    6.0       6.0  

Average expected volatility

    72 %     75 %

Risk-free interest rate

    1.98 %     0.95 %

Expected dividend yield

    2.30 %      

Weighted average grant date fair value - ($/share)

  $ 2.84     $ 2.07  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
   

Number of Shares Underlying Options

   

Weighted Average Exercise Price Per Share

   

Weighted Average Remaining Contractual Term

   

Aggregate Intrinsic Value

 
   

(in thousands)

           

(in years)

         

Outstanding at January 1, 2022

    359     $ 1.96                  

Granted

    241       6.41                  

Exercised

                           

Unvested shares forfeited

                           

Vested shares expired

                           

Outstanding at June 30, 2022

    600     $ 3.75       8.84     $ 1,916  

Exercisable at June 30, 2022

    194     $ 1.68       8.16     $ 1,017  
   

Number of Shares Underlying Options

   

Weighted Average Exercise Price Per Share

   

Weighted Average Remaining Contractual Term

   

Aggregate Intrinsic Value

 
   

(in thousands)

           

(in years)

         

Outstanding at January 1, 2022

    615     $ 1.58                  

Granted

                           

Exercised

    (229 )     1.12                  

Unvested shares forfeited

                           

Vested shares expired

                           

Outstanding at June 30, 2022

    386     $ 1.86       1.46     $ 1,965  

Exercisable at June 30, 2022

    386     $ 1.86       1.46     $ 1,965  
Nonvested Restricted Stock Shares Activity [Table Text Block]
   

Restricted Stock

   

Weighted Average Grant Date Fair Value

 
   

(in thousands)

         

Non-vested shares outstanding at January 1, 2022

    741     $ 2.36  

Awards granted

    384       6.56  

Awards vested

    (334 )     2.25  

Awards forfeited

    (30 )     3.50  

Non-vested shares outstanding at June 30, 2022

    761     $ 4.48  
Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]
   

Number of Shares Underlying SARs

   

Weighted Average Exercise Price Per Share

   

Weight Average Remaining Contractual Term

   

Aggregate Intrinsic Value

 
   

(in thousands)

           

(in years)

   

(in thousands)

 

Outstanding at January 1, 2022

    362     $ 1.81                  

Granted

                           

Exercised

    (153 )     1.71                  

Unvested SARs forfeited

                           

Vested SARs expired

                           

Outstanding at June 30, 2022

    209     $ 1.88       1.36     $ 1,055  

Exercisable at June 30, 2022

    209     $ 1.88       1.36     $ 1,055